Status:
COMPLETED
Results of Adjunctive Intraoperative Bevacizumab Injection on Trabeculectomy Outcome
Lead Sponsor:
Prince of Songkla University
Conditions:
Glaucoma
Eligibility:
All Genders
18-80 years
Phase:
PHASE2
PHASE3
Brief Summary
The purpose of this study is to evaluate the adjunctive effect of intratenon Bevacizumab on the result of trabeculectomy in primary term of intraocular pressure (IOP).
Detailed Description
Prospective interventional clinical trial Single center, outcome assessor-masked, active control, randomized controlled trial
Eligibility Criteria
Inclusion
- Primary open angle glaucoma with primary mmc-trabeculectomy indication
Exclusion
- combined phacoemulsification with trabeculectomy
- no more than 6 month of cataract surgery before trabeculectomy
- revised trabeculectomy
- active uveitic glaucoma
- neovascular glaucoma
- par planar vitrectomy
- conjunctival surgery
- allergy to bevacizumab or mitomycin C
- ischemic heart disease
- cerebrovascular disease
- renal failure
- liver failure
Key Trial Info
Start Date :
December 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2014
Estimated Enrollment :
39 Patients enrolled
Trial Details
Trial ID
NCT01263834
Start Date
December 1 2010
End Date
January 1 2014
Last Update
January 31 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Glaucoma unit , Department of Ophthalmology Faculty of Medicine Prince of Songkla University
Hat Yai, Changwat Songkhla, Thailand, 90110